Abnormal premotor–motor interaction in heterozygous Parkin- and Pink1 mutation carriers
•Asymptomatic heterozygous Parkin/PINK1 mutation carriers show altered premotor–motor inhibition.•A single l-dopa administration could partly reverse this alteration.•These mutation carriers can serve as in vivo models to study pre-symptomatic stages of Parkinsonism. Mutations in the Parkin and PINK...
Saved in:
Published in | Clinical neurophysiology Vol. 128; no. 1; pp. 275 - 280 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.01.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | •Asymptomatic heterozygous Parkin/PINK1 mutation carriers show altered premotor–motor inhibition.•A single l-dopa administration could partly reverse this alteration.•These mutation carriers can serve as in vivo models to study pre-symptomatic stages of Parkinsonism.
Mutations in the Parkin and PINK1 gene account for the majority of autosomal recessive early-onset Parkinson cases. There is increasing evidence that clinically asymptomatic subjects with single heterozygous mutations have a latent nigrostriatal dopaminergic deficit and could be taken as in vivo model of pre-symptomatic phase of Parkinsonism.
We charted premotor–motor excitability changes as compensatory mechanisms for subcortical dopamine depletions using transcranial magnetic stimulation by applying magnetic resonance-navigated premotor–motor cortex conditioning in 15 asymptomatic, heterozygous Parkin and PINK1 mutation carriers (2 female; mean age 53±8years) and 16 age- and sex-matched controls (5 female; mean age 57±9years). Participants were examined at baseline and after acute l-dopa challenge.
There were l-dopa and group specific effects during premotor–motor conditioning at an interstimulus interval of 6ms indicating a normalisation of premotor–motor interactions in heterozygous Parkin and PINK1 mutation carriers after l-dopa intake. Non-physiologically high conditioned MEP amplitudes at this interval in mutation carriers decreased after l-dopa intake but increased in controls.
Premotor–motor excitability changes are part of the cortical reorganization in asymptomatic heterozygous Parkin- and PINK1 mutation carriers.
These subjects offer opportunities to delineate motor network adaptation in pre-symptomatic Parkinsonism. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1388-2457 1872-8952 |
DOI: | 10.1016/j.clinph.2016.10.007 |